The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.
Radar 87 (high attention) · dilution pressure high · listing risk high · governance risk elevated · runway 0.3 mo · strongest signal: Convertible note (Aug 28, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (going concern in 8-k) coexists with live selling machinery (convertible note, equity line, shelf filed). Base case is a discounted raise; the question is when, not if.
Variable-priced paper is outstanding while the listing is under stress — the structure where dilution can accelerate. Watch the share count each quarter. Discount-priced or variable-priced securities are outstanding while the company is managing its listing with reverse splits/notices. Each conversion lowers the price, which lowers the next conversion price.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 175 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Sep 16, 2026 | ▼ Reverse split | “reverse split” language in DEF 14A (DEF 14A) filed 2026-09-16 filing | 30 |
| Sep 14, 2026 | ▼ Shelf filed | S-1/A filed 2026-09-14 filing | 32 |
| Sep 4, 2026 | ▼ Reverse split | “reverse split” language in PRE 14A (PRE 14A) filed 2026-09-04 filing | 30 |
| Aug 28, 2026 | ▼ Convertible note | “convertible note” language in 8-K (EX-10.1) filed 2026-08-28 filing | 45 |
| Aug 28, 2026 | ▼ Equity line | “equity line” language in 8-K (8-K) filed 2026-08-28 filing | 45 |
| Aug 28, 2026 | ▼ Reverse split | “reverse split” language in 8-K (EX-10.1) filed 2026-08-28 filing | 35 |
| Aug 28, 2026 | · Officer/director change | 8-K Item 5.02 filed 2026-08-28 (accepted 17:00 ET) filing | 24 |
| Aug 24, 2026 | ▼ Shelf filed | S-1 filed 2026-08-24 filing | 35 |
| Aug 24, 2026 | ▼ Delisting language | “delisting notice” language in 8-K (EX-99.1) filed 2026-08-24 filing | 32 |
| Aug 24, 2026 | ▼ Going concern in 8-K | “going concern 8k” language in 8-K (EX-99.1) filed 2026-08-24 filing | 31 |
| Aug 24, 2026 | · Officer/director change | 8-K Item 5.02 filed 2026-08-24 (accepted 16:10 ET) filing | 22 |
| Mar 31, 2026 | ▼ Runway < 6 months | ~0.3 months runway: liquidity $27,000 as of 2026-03-31, burn $1,061,000/yr (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts]) filing | 38 |
| Mar 31, 2026 | ▼ Near $5M MVLS floor | Public float $2,960,372 (as of 2025-06-30) vs $5M Nasdaq MVLS floor; needs price x shares confirmation filing | 29 |
| Mar 31, 2026 | ▼ Cash < current liabilities | Liquidity $27,000 vs current liabilities $9,057,000 filing | 22 |
SDST Stardust Power Inc. · GOVX GeoVax Labs, Inc. · MYSZ My Size, Inc. · SNTI Senti Biosciences Holdings, · GCTK Glucotrack, Inc. · SOAR Volato Group, Inc. · screener →